Full-Time

Manager – Computational Biology

Early Oncology

Recursion Pharmaceuticals

Recursion Pharmaceuticals

501-1,000 employees

Clinical-stage biotechnology company for drug discovery

Compensation Overview

$151.8k - $230k/yr

+ Bonus + Equity

Salt Lake City, UT, USA + 1 more

More locations: New York, NY, USA

Hybrid

Hybrid role; must work in-office at least 50% of the time in New York City or Salt Lake City.

Category
Biology & Biotech (1)
Required Skills
Python
R
Requirements
  • PhD in a quantitative field in Computational Biology, Bioinformatics, Statistics, Cancer Biology, or related field with 5+ years of experience in biotech or pharma industry, OR MS in a relevant field with 7+ years of experience in biotech or pharma industry solving fundamental problems in oncology or drug discovery
  • People management experience (proven track record of managing and developing direct reports)
  • Oncology domain expertise with deep understanding of cancer biology, including experience with biomarker discovery and patient population stratification
  • Experience with two or more oncology areas; strong understanding of patient genetics and historical druggability of disease-relevant pathways
  • Deep expertise in the analysis and data integration of two or more omics modalities (phenomics, transcriptomics, proteomics, genomics), including experience working with patient data
  • Exceptional data visualization skills
  • Computational proficiency in Python or R for analysis of high-dimensional biological data
  • Excellent cross-functional communication
Responsibilities
  • Lead and develop a team of data scientists and computational biologists, fostering a culture of scientific rigor, bold experimentation, and continuous professional growth
  • Drive target discovery by leading design and execution of analyses for target nomination and validation using Recursion’s platform to identify novel vulnerabilities in cancer biology
  • Define early patient population strategy by developing biomarker strategies and patient-stratification hypotheses to support programs as they progress from nomination through hit-to-lead and lead-optimization
  • Bridge the gap by acting as a key connector, leading the team to pilot innovative analysis methods and collaborating with platform and engineering teams to productionalize and scale tools for organization-wide impact
  • Execute hands-on work with a 50% individual contribution load, performing complex data integration and analysis to solve killer questions within the oncology portfolio
  • Collaborate cross-functionally by partnering with biologists, medicinal chemists, and clinical leads to build compelling data packages that drive program milestones and investment decisions
  • Present data analysis to external decision makers and stakeholders in a clear and compelling way that drives toward getting medicines to patients
Desired Qualifications
  • Public data mastery: Familiarity with large-scale oncology datasets such as TCGA, CCLE, DepMap, and/or Real-World Data
  • Experimental design: Experience designing high-throughput screens or CRISPR/small-molecule perturbations to validate therapeutic hypotheses
  • Clinical translation: Exposure to the requirements for Investigational New Drug-enabling studies or clinical trial biomarker analysis
Recursion Pharmaceuticals

Recursion Pharmaceuticals

View

Recursion is a clinical-stage biotechnology company utilizing a synchronized combination of hardware, software, and data to industrialize drug discovery and decode complex biology, reshaping the traditional drug discovery funnel through technological innovations. Their approach integrates biology, chemistry, automation, and data science to build a next-generation biopharmaceutical company.

Company Size

501-1,000

Company Stage

Post IPO Equity

Headquarters

Salt Lake City, Utah

Founded

2013

Your Connections

People at Recursion Pharmaceuticals who can refer or advise you

Growth & Insights

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%